Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 22, 2021
JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara®-Induced Skin InflammationAurore Le, Abdulkader Azouz, Séverine Thomas, et al.
Frontiers in Immunology|March 30, 2023
Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector TregsNatalia Bowakim-Anta, Valérie Acolty, Abdulkader Azouz, et al.
Frontiers in Immunology|January 31, 2020
Multiple Environmental Signaling Pathways Control the Differentiation of RORγt-Expressing Regulatory T CellsHind Hussein, Sébastien Denanglaire, Frédéric Van Gool, et al.
Elife|February 22, 2022
The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cellsYousra Ajouaou, Abdulkader Azouz, Anaëlle Taquin, et al.
JCI Insight|May 6, 2020
Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophagesEmmanuelle Alaluf, Benoît Vokaer, Aurélie Detavernier, et al.
Nature Communications|May 9, 2015
Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8(+) T cellsValérie Martinet, Sandrine Tonon, David Torres, et al.
Cancer Immunology Research|August 28, 2025
IFNγ-induced PD-L1+MHC II+ macrophages and Tim-3+ tumor-reactive CD8+ T cells predict a response to anti-PD-1 therapy in tumor-bearing miceJelena Gabrilo, Sylvie Vande Velde, Coralie Henin, et al.
Nature Communications|July 26, 2019
EOMES interacts with RUNX3 and BRG1 to promote innate memory cell formation through epigenetic reprogrammingNicolas Istaces, Marion Splittgerber, Viviana Lima Silva, et al.
Cancer Immunology Research|January 5, 2023
PHD2 Constrains Antitumor CD8+ T-cell ActivityCharlotte Bisilliat Donnet, Valérie Acolty, Abdulkader Azouz, et al.
Pageof 3